Promises and challenges of personalized medicine to guide ARDS therapy.
Crit Care
; 25(1): 404, 2021 11 23.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1745432
ABSTRACT
Identifying new effective treatments for the acute respiratory distress syndrome (ARDS), including COVID-19 ARDS, remains a challenge. The field of ARDS investigation is moving increasingly toward innovative approaches such as the personalization of therapy to biological and clinical sub-phenotypes. Additionally, there is growing recognition of the importance of the global context to identify effective ARDS treatments. This review highlights emerging opportunities and continued challenges for personalizing therapy for ARDS, from identifying treatable traits to innovative clinical trial design and recognition of patient-level factors as the field of critical care investigation moves forward into the twenty-first century.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Síndrome de Dificultad Respiratoria
/
Medicina de Precisión
Tipo de estudio:
Estudio pronóstico
/
Ensayo controlado aleatorizado
Tópicos:
Covid persistente
Límite:
Humanos
Idioma:
Inglés
Revista:
Crit Care
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
S13054-021-03822-z
Similares
MEDLINE
...
LILACS
LIS